 WALTHAM, Mass., Jan. 03, 2023 GLOBE NEWSWIRE -- Apellis Pharmaceuticals , Inc. Nasdaq: APLS, a global biopharmaceutical company and leader in complement, today announced that the company will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 9:00 a.m. PT 12:00 p.m. ET. 